IQVIA Holdings Inc. (IQV) Earnings Per Share (EPS): 8.07
Is IQVIA Holdings Inc.’s earnings per share (EPS) high or low?
IQVIA Holdings Inc.'s earnings per share (EPS) of 8.07 is 38% above its 5-year average of 5.87, near the high end of its 5-year range (1.46–7.91).
The earnings per share (EPS) for IQVIA Holdings Inc. (IQV) is 8.07 as of Wednesday, June 10, 2026. It is above its 12-month average by 4.26% (7.74).
IQV Earnings Per Share (EPS) Chart
IQV Average Earnings Per Share (EPS) Chart
IQV Current vs Average Earnings Per Share (EPS) Chart
IQV Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
8.07
EARNINGS PER SHARE (EPS) AVG TTM
7.74
EARNINGS PER SHARE (EPS) AVG 3Y
7.17
EARNINGS PER SHARE (EPS) AVG 5Y
5.87
EARNINGS PER SHARE (EPS) AVG 10Y
4.31
EARNINGS PER SHARE (EPS) AVG 15Y
3.54
EARNINGS PER SHARE (EPS) AVG 20Y
3.54
CURRENT VS TTM AVG
+4.26%
CURRENT VS 3Y AVG
+12.51%
CURRENT VS 5Y AVG
+37.56%
CURRENT VS 10Y AVG
+87.36%
CURRENT VS 15Y AVG
+128.05%
CURRENT VS 20Y AVG
+128.05%
IQV Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | — | 8.07 | 7.74 | 7.17 | 5.87 |
| Centene Corporation (CNC) | $31.94B | -13.14 | -3.64 | -0.05 | 0.88 |
| DexCom, Inc. (DXCM) | $29.24B | 2.34 | 1.80 | 1.48 | 1.30 |
| Biogen Inc. (BIIB) | $29.00B | 9.34 | 10.02 | 12.26 | 14.06 |
| Veeva Systems Inc. (VEEV) | $27.37B | 5.61 | 4.98 | 4.09 | 3.61 |
| Zoetis Inc. (ZTS) | $34.20B | 6.03 | 5.75 | 5.27 | 4.80 |
| Waters Corporation (WAT) | $23.83B | 7.87 | 10.78 | 11.05 | 10.65 |
| Agilent Technologies, Inc. (A) | $38.26B | 4.98 | 4.52 | 4.36 | 3.96 |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 42.71 | 41.42 | 39.43 | 36.04 |
| BioNTech SE (BNTX) | $21.81B | -5.94 | -4.08 | 9.21 | 14.48 |
EPS Comparison
Trailing EPS (TTM)
$8.07
Forward EPS (Est.)
$14.15
P/E Ratio
22.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
IQVIA Holdings Inc. Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IQVIA Holdings Inc. Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The earnings per share (EPS) for IQV stock is 8.07.
- Is IQVIA Holdings Inc.'s earnings per share (EPS) high or low?
- IQVIA Holdings Inc.'s earnings per share (EPS) of 8.07 is 38% above its 5-year average of 5.87, near the high end of its 5-year range (1.46–7.91).
- What is the TTM average earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The TTM average earnings per share (EPS) for IQV stock is 7.74.
- What is the 3Y average earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The 3Y average earnings per share (EPS) for IQV stock is 7.17.
- What is the 5Y average earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The 5Y average earnings per share (EPS) for IQV stock is 5.87.
- What is the 10Y average earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The 10Y average earnings per share (EPS) for IQV stock is 4.31.
- What is the 15Y average earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The 15Y average earnings per share (EPS) for IQV stock is 3.54.
- What is the 20Y average earnings per share (EPS) for IQVIA Holdings Inc. (IQV)?
- The 20Y average earnings per share (EPS) for IQV stock is 3.54.
IQVIA Holdings Inc. Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 7.91 |
| 2024-12-31 | 7.57 |
| 2023-12-31 | 7.39 |
| 2022-12-31 | 5.82 |
| 2021-12-31 | 5.05 |
| 2020-12-31 | 1.46 |
| 2019-12-31 | 0.98 |
| 2018-12-31 | 1.27 |
| 2017-12-31 | 6.01 |
| 2016-12-31 | 0.77 |
| 2015-12-31 | 3.15 |
| 2014-12-31 | 2.78 |
| 2013-12-31 | 1.83 |
| 2012-12-31 | 1.42 |
| 2011-12-31 | 1.93 |
| 2010-12-31 | 1.28 |
Related Metrics
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib